Triallelic and epigenetic-like inheritance in human disorders of telomerase
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
Key Points: Telomerase variants in patients with bone marrow failure syndromes are difficult to categorize as disease-causing or otherwise. DC can derive from triallelic mutations in 2 telomerase genes and epigenetic-like inheritance of short telomeres.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shelterin: the protein complex that shapes and safeguards human telomeres
de Lange, T. (2005) · Genes & Development · doi:10.1101/gad.1346005 · Cited by 3,056 · cited 1×
“In association with proteins of the shelterin complex, telomeres also prevent the chromosome ends from being recognized as a doublestrand breaks and being inappropriately subjected to DNA damage repair mechanisms.(10) Genetic variants in TERC and TERT are frequently seen in DC patients, accounting for;10%of cases.”
A survey of telomerase activity in human cancer
Shay, J. W., & Bacchetti, S. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00062-2 · Cited by 2,794 · cited 1×
“In some stem cells and in the germline, telomere shortening can be compensated by the action of telomerase.(9) This ribonucleoprotein complex is composed of 2 key components, the reverse transcriptase (TERT) and the RNA component (TERC).”
BackgroundTelomerase Mutations in Families with Idiopathic Pulmonary Fibrosis
Armanios, M. Y., Chen, J. J.-L., Cogan, J. D., Alder, J. K., Ingersoll, R. G., Markin, C., Lawson, W. E., Xie, M., Vulto, I., Phillips, J. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066157 · Cited by 1,357
Incidence and Prevalence of Idiopathic Pulmonary Fibrosis
Raghu, G., Weycker, D., Edelsberg, J., Bradford, W. Z., & Oster, G. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200602-163oc · Cited by 1,310 · cited 1×
“7 in 100 000.(39) We therefore suggest that if a TERT variant in a patient with pulmonary fibrosis appears on ExAC it should not be ruled out as a bystander without further investigation.”
BackgroundA Systematic Survey of Loss-of-Function Variants in Human Protein-Coding Genes
MacArthur, D. G., Balasubramanian, S., Frankish, A., Huang, N., Morris, J., Walter, K., Jostins, L., Habegger, L., Pickrell, J. K., Montgomery, S. B., et al. (2012) · Science · doi:10.1126/science.1215040 · Cited by 1,272
Armanios, M., & Blackburn, E. H. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3246 · Cited by 982 · cited 1×
“The telomeropathies are a collection of disorders characterized by impaired telomere maintenance.(1,2) The classic example of this is the inherited bonemarrow failure (BMF) syndromedyskeratosis congenita (DC).”
BackgroundThe RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita
Vulliamy, T., Marrone, A., Goldman, F., Dearlove, A., Bessler, M., Mason, P. J., & Dokal, I. (2001) · Nature · doi:10.1038/35096585 · Cited by 960
Self-citationAdult-onset pulmonary fibrosis caused by mutations in telomerase
Tsakiri, K. D., Cronkhite, J. T., Kuan, P. J., Xing, C., Raghu, G., Weissler, J. C., Rosenblatt, R. L., Shay, J. W., & Garcia, C. K. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0701009104 · Cited by 894
Mutations in TERT, the Gene for Telomerase Reverse Transcriptase, in Aplastic Anemia
Yamaguchi, H., Calado, R. T., Ly, H., Kajigaya, S., Baerlocher, G. M., Chanock, S. J., Lansdorp, P. M., & Young, N. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042980 · Cited by 723
Vulliamy, T., Marrone, A., Szydlo, R., Walne, A., Mason, P. J., & Dokal, I. (2004) · Nature Genetics · doi:10.1038/ng1346 · Cited by 461 · cited 1×
“Although TERC andTERT variants are associatedwith a number of disease phenotypes, the investigation of telomerase variants is further complicated by variable penetrance within families, late onset of disease, subclinical features, anddisease anticipationdue to progressive telomere shortening through successive generat…”
BackgroundSelf-citation
Cited by
Blackburn, E. H., Epel, E. S., & Lin, J. (2015) · Science · doi:10.1126/science.aab3389 · Cited by 1,596
Stress, telomeres, and psychopathology: toward a deeper understanding of a triad of early aging
Epel, E. S., & Prather, A. A. (2018) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-032816-045054 · Cited by 153
TERC promotes cellular inflammatory response independent of telomerase
Liu, H., Yang, Y., Ge, Y., Liu, J., & Zhao, Y. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz584 · Cited by 88
Metadata
- Authors
- Collopy, L. C., Walne, A. J., Cardoso, S., de la Fuente, J., Mohamed, M., Toriello, H., Tamary, H., Ling, A. J. Y. V., Lloyd, T., Kassam, R., Tummala, H., Vulliamy, T. J., & Dokal, I.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2015-07-09
- Volume
- 126
- Issue
- 2
- Pages
- 176-184
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W1608299731
- Cited by
- 63
- References
- 19
- FWCI
- 4.73
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Triallelic and epigenetic-like inheritance in human disorders of telomerase. https://app.cochat.ai/papers/10.1182/blood-2015-03-633388
- The paper
- Collopy, L. C., Walne, A. J., Cardoso, S., de la Fuente, J., Mohamed, M., Toriello, H., Tamary, H., Ling, A. J. Y. V., Lloyd, T., Kassam, R., Tummala, H., Vulliamy, T. J., & Dokal, I. (2015). Triallelic and epigenetic-like inheritance in human disorders of telomerase. Blood. https://doi.org/10.1182/blood-2015-03-633388
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.